Writing for The Atlantic, Dr. Ezekiel Emanuel accuses the biopharmaceutical industry of being “deceptive” when it seeks to explain the cost of prescription drugs. But in making this claim, Dr. Emanuel is guilty of engaging in some of his own acts of deception. For starters, drug prices are not …

In celebration of International Women’s Day on March 8th, women across the globe are leading the charge for balance and equality. This year’s tagline and theme, #BalanceforBetter, seeks a more gender-balanced world through celebrating women’s achievements and raising awareness about bias. One event…

In recognition of Rare Disease Day, BIO’s Jim Greenwood shared commentary on LinkedIn celebrating the success of the Orphan Drug Act and highlighting the importance of preserving incentives to help spur the development of new drugs in this space. “The truth is, incentives provided by the ODA have…

Two of our most beloved breakfast beverages — coffee and orange juice — are under serious threat from disease, insects and climate change. But don’t be too alarmed. Scientists are looking at innovative new ways to protect and strengthen coffee plants and citrus trees. With gene editing and the…

It’s hard to miss the news coming from the Pacific Northwest. Every major media outlet is covering the latest measles outbreak. Social media feeds are loaded with real-time data as the virus continues to spread. And the state of Washington has officially declared a State of Emergency. In case the…

As part of the 90-day trade negotiations between the United States and China, today Chinese Vice Premier Liu He is in Washington to participate in bilateral trade talks with the Trump administration. One major component the Trump administration has pushed for in such trade talks is structural…

Writing for The Hill, BIO’s President and CEO Jim Greenwood shined a spotlight on a shocking Wall Street Journal investigation showing how health insurance companies in the U.S. dramatically inflated their cost projections under Medicare Part D for financial gain over a 10 year period: “Under…